Amgen Inc. (AMGN) — closed signal from February 25, 2026
Partial Published before the outcome was known, scored automatically when the window closed on May 26, 2026.
Predicted vs. what happened
What happened
Reached 11% of the predicted growth at its peak, without hitting the target.
The thesis — published February 25, 2026
Amgen will speak at a healthcare conference on March 2, which can remind investors about its drug pipeline. If the company's message is clear and trading after the event shows buyers stepping in, short-term interest from healthcare-focused investors could push the stock higher. The plan is to buy on small drops and only add if buyers stay in control after the event.
Primary drivers
- March 2 conference can highlight Amgen's drug pipeline and plans
- Investors may move into healthcare stocks when growth gets uncertain
- The stock has been on a steady path up with controlled swings
- Clear messaging after the event could make investors value shares higher
How it played out
AMGN: the target was not reached
Lyra published AMGN at $387.17 on 2026-02-25 with a short-term thesis for 10% expected growth. The thesis pointed to a March 2 healthcare conference, possible attention on the drug pipeline, steadier healthcare demand when growth was uncertain, controlled price swings, and clearer messaging after the event.
Inside the window from 2026-02-25 to 2026-05-26, AMGN peaked at $391.29 on 2026-03-02, a 1.1% gain. It stayed below the $425.89 target. The stock ended at $339.30. The thesis only partially played out: there was a small early move, but it never got there.
What happened during the window
On April 30, 2026, Amgen reported first-quarter revenue of $8.62 billion and adjusted earnings of $5.15 per share. The same report said 2026 revenue guidance was $37.1 billion to $38.5 billion.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.